Fellow

Fellow Health, founded in 2018, operates within the burgeoning male reproductive health market, offering a direct-to-consumer platform for clinical-grade semen analysis and cryopreservation. The company was brought to life by co-founders Teddy Maggiani, Samuel Hollander, and CEO Gideon Akande, who experienced personal frustrations with the traditional, often awkward and inconvenient process of fertility testing in a clinical setting. This firsthand experience was the catalyst for creating a more private, accessible, and user-friendly alternative.

The business model centers on selling at-home collection kits directly to consumers, providing a discreet method for sample collection. Once collected, the sample is shipped overnight to Fellow's CLIA-certified laboratory for analysis. This positions the company in the health-tech and diagnostics sector, targeting individuals and couples seeking fertility insights, as well as patients undergoing post-vasectomy checks. Revenue is generated through the sale of these kits, which include the 'Fellow Semen Analysis' for a comprehensive fertility workup and the 'Fellow Post-Vasectomy Test'. Beyond diagnostics, Fellow offers a cryopreservation service, allowing clients to freeze and store their sperm for future use, creating a recurring revenue stream through storage fees.

The core service leverages a proprietary, patent-pending preservation technology that stabilizes the sperm sample at room temperature, ensuring its viability during transit to the lab without the need for cold storage. This is a key differentiator from traditional methods. Upon analysis, clients receive a detailed, easy-to-understand report covering critical parameters such as sperm count, concentration, motility, and morphology, which is accessible through a secure online portal. The company has secured FDA clearance for its collection kit, underscoring its commitment to clinical standards. Having raised a total of $7.5 million in funding, Fellow is capitalized to expand its reach and challenge the conventional norms of male fertility services.

Keywords: male fertility, sperm testing, cryopreservation, at-home diagnostics, health-tech, reproductive health, semen analysis, direct-to-consumer healthcare, post-vasectomy testing, fertility solutions